Cargando…
Mortality in pediatric oncology and stem cell transplant patients with bloodstream infections
BACKGROUND: Bloodstream infections (BSI) continue to represent a significant source of morbidity for pediatric oncology patients, however less is known regarding this population’s risk of death. We sought to evaluate the risk of BSI and death at a large pediatric cancer center. METHODS: We retrospec...
Autores principales: | Willis, Daniel N., McGlynn, Mary Claire, Reich, Patrick J., Hayashi, Robert J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9874914/ https://www.ncbi.nlm.nih.gov/pubmed/36713545 http://dx.doi.org/10.3389/fonc.2022.1063253 |
Ejemplares similares
-
Factors influencing delayed clearance of high dose methotrexate (HDMTX) in pediatric, adolescent, and young adult oncology patients
por: Mosleh, Ema, et al.
Publicado: (2023) -
Stenotrophomonas maltophilia Infections in Pediatric Patients – Experience at a European Center for Pediatric Hematology and Oncology
por: Zöllner, Stefan K., et al.
Publicado: (2021) -
Eliminating Central Line Associated Bloodstream Infections in Pediatric Oncology Patients: A Quality Improvement Effort
por: Willis, Daniel N., et al.
Publicado: (2023) -
Pulmonary Complications After Pediatric Stem Cell Transplant
por: Fitch, Taylor, et al.
Publicado: (2021) -
Microbiology and Risk Factors for Hospital-Associated Bloodstream Infections Among Pediatric Hematopoietic Stem Cell Transplant Recipients
por: Akinboyo, Ibukunoluwa C, et al.
Publicado: (2020)